CIMT 2021: report on the 18th Annual Meeting of the Association for Cancer Immunotherapy

CIMT 2021: report on the 18th Annual Meeting of the Association for Cancer Immunotherapy

After one year of absence, the 18th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Europe’s cancer immunotherapy meeting, took place virtually from 10 to 12 May 2021. Over 850 academic and clinical professionals from 30 countries met to discuss the recent advancements in cancer i...

Full description

Bibliographic Details
Main Authors:	Arne Billmeier, Krutika Khinvasara, Franziska Lang, Julia Mohr, Daniel Reidenbach, Maik Schork, Ikra Yildiz, Mustafa Diken
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2022-01-01
Series:	Human Vaccines & Immunotherapeutics
Subjects:	cimt cancer immunotherapy tumor vaccination cellular therapy combination therapy tumor microenvironment checkpoint blockade personalized therapy covid19
Online Access:	http://dx.doi.org/10.1080/21645515.2021.2024416

Similar Items

CIMT 2019: report on the 17th Annual Meeting of the Association for Cancer Immunotherapy
by: Jan David Beck, et al.
Published: (2020-04-01)

CIMT 2022: Report on the 19th Annual Meeting of the Association for Cancer Immunotherapy
by: Peer Andre Berger, et al.
Published: (2022-11-01)

CIMT 2018: Pushing frontiers in cancer immunotherapy — Report on the 16th Annual Meeting of the Association for Cancer Immunotherapy
by: Jan Beck, et al.
Published: (2018-12-01)

CIMT 2017: Anniversary symposium - Report on the 15th CIMT Annual Meeting of the Association for Cancer Immunotherapy
by: Lena M. Kranz, et al.
Published: (2017-10-01)

CIMT 2023: report on the 20th Annual Meeting of the Association for Cancer Immunotherapy
by: J. Dallmann, et al.
Published: (2023-12-01)

Application of CIMT-therapy technique in cerebral palsy
by: Iryna Bivol, et al.
Published: (2022-06-01)

Immuno-Oncology: Emerging Targets and Combination Therapies
by: Henry T. Marshall, et al.
Published: (2018-08-01)

An experimental model of anti-PD-1 resistance exhibits activation of TGFß and Notch pathways and is sensitive to local mRNA immunotherapy
by: Marie Bernardo, et al.
Published: (2021-01-01)

The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies
by: Ciliang Guo, et al.
Published: (2023-10-01)

Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer
by: Yichi Zhang, et al.
Published: (2022-01-01)

Combination of immune checkpoint blockade and targeted gene regulation of angiogenesis for facilitating antitumor immunotherapy
by: Jing Zhan, et al.
Published: (2023-03-01)

Alpha radionuclide-chelated radioimmunotherapy promoters enable local radiotherapy/chemodynamic therapy to discourage cancer progression
by: Jiajia Zhang, et al.
Published: (2022-09-01)

The Effect of Virtual Rehabilitation and Constraint Induced Movement Therapy (CIMT) on Improving Upper Extremity Motor Activity Post-Stroke
by: Aiman Farogh Anjum, Humaira Fayyaz, Arif Siddiqui
Published: (2017-09-01)

Immune Checkpoint Blockade via PD-L1 Potentiates More CD28-Based than 4-1BB-Based Anti-Carbonic Anhydrase IX Chimeric Antigen Receptor T Cells
by: Najla Santos Pacheco de Campos, et al.
Published: (2022-05-01)

Advances in PD-1 signaling inhibition-based nano-delivery systems for tumor therapy
by: Songlin Liu, et al.
Published: (2023-07-01)

Dendritic Cells and Cancer: From Biology to Therapeutic Intervention
by: Ben Wylie, et al.
Published: (2019-04-01)

Nanomaterials-based precision sonodynamic therapy enhancing immune checkpoint blockade: A promising strategy targeting solid tumor
by: Xinlun Dai, et al.
Published: (2023-12-01)

Modern cancer therapy: cryoablation meets immune checkpoint blockade
by: Qi Liu, et al.
Published: (2024-02-01)

Engineering nanoparticles to reprogram radiotherapy and immunotherapy: recent advances and future challenges
by: Jing Jin, et al.
Published: (2020-05-01)

Manipulation of the crosstalk between tumor angiogenesis and immunosuppression in the tumor microenvironment: Insight into the combination therapy of anti-angiogenesis and immune checkpoint blockade
by: Weiwei Zheng, et al.
Published: (2022-11-01)

Strategies to reinvigorate exhausted CD8+ T cells in tumor microenvironment
by: Qianting Guan, et al.
Published: (2023-06-01)

Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th–December 1st, 2022)
by: Paolo A. Ascierto, et al.
Published: (2023-07-01)

9th Immunotherapy of Cancer conference (ITOC): A meeting report
by: Iman Dalloul, et al.
Published: (2022-12-01)

T Cells in Colorectal Cancer: Unravelling the Function of Different T Cell Subsets in the Tumor Microenvironment
by: Ziwen Zheng, et al.
Published: (2023-07-01)

Editorial: Targeting metabolism to activate T cells and enhance the efficacy of checkpoint blockade immunotherapy in solid tumors
by: Zhijia Xia, et al.
Published: (2023-07-01)

An Able-Bodied Study for Potential Usage of a Knee Scooter as a Constraint-Induced Movement Therapy (CIMT) Gait Training Device
by: Jaewook Kim, et al.
Published: (2024-03-01)

Combination of phototherapy with immune checkpoint blockade: Theory and practice in cancer
by: Yujie Zhao, et al.
Published: (2022-09-01)

Advancements in Cancer Immunotherapies
by: Ruchi Roy, et al.
Published: (2022-12-01)

Editorial: Gastrointestinal cancer immunotherapy: from drug resistance mechanisms to overcoming strategies
by: Tao Shi, et al.
Published: (2023-06-01)

M2 macrophage-derived exosomes suppress tumor intrinsic immunogenicity to confer immunotherapy resistance
by: Naisheng Zheng, et al.
Published: (2023-12-01)

The tactics of the restoration of the movement of the upper limb after a postered traumatic brain injury by physical rehabilitation
by: Nadezhda Bogdanovska
Published: (2021-11-01)

Next-generation CTLA-4 targeting molecules and combination therapy: promising strategies for improving cancer immunotherapy
by: Nils-Petter Rudqvist, et al.
Published: (2023-12-01)

Photothermally sensitive gold nanocage augments the antitumor efficiency of immune checkpoint blockade in immune “cold” tumors
by: Guixiu Xiao, et al.
Published: (2023-10-01)

Microfluidic synthesis of fibronectin-coated polydopamine nanocomplexes for self-supplementing tumor microenvironment regulation and MR imaging-guided chemo-chemodynamic-immune therapy
by: Rui Yang, et al.
Published: (2023-06-01)

ACAP1 Deficiency Predicts Inferior Immunotherapy Response in Solid Tumors
by: Qiyi Yi, et al.
Published: (2022-12-01)

Chimeric Antigen Receptor T-Cell Therapy: The Light of Day for Osteosarcoma
by: Zili Lin, et al.
Published: (2021-09-01)

Cancer Vaccines and Immunotherapy for Tumor Prevention and Treatment
by: Jagmohan Singh, et al.
Published: (2021-11-01)

Targeted protein degradation in hematologic malignancies: latest updates from the 2023 ASH annual meeting
by: Guangcai Zhong, et al.
Published: (2024-03-01)

Targeting the epigenome to reinvigorate T cells for cancer immunotherapy
by: Dian Xiong, et al.
Published: (2023-12-01)

A ROS-responsive synergistic delivery system for combined immunotherapy and chemotherapy
by: Doudou Hu, et al.
Published: (2022-03-01)